![]() |
Custom Search
|
A vaccine to treat prostate cancer came one step closer to approval last week, when an advisory panel to the US Food and Drug Administration said the product was safe and effective. The panel recommended the FDA approve Provenge (sipuleucel-T), ... Read the entire article at American Cancer Society | ||||
|